Breaks Categories: News

TuesdayJan 04, 2022 12:18 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Foray into Mexico, Showcased in Latest Episode of ‘Bell2Bell’ Podcast

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products, today announced that its Mind Naturals skincare brand has launched sales through Walmart.com and Coppel, a nationwide department store in Mexico. According to the update, the launch includes 12 products from the Mind Naturals portfolio, initially via e-commerce with subsequent plans to sell in brick-and-mortar retail locations. “We are excited to begin bringing high-quality, sustainable CBD skincare products to Mexico,” said Luis Merchan, CEO of Flora Growth Corp. “This agreement represents our first foray into the Mexican market and furthers our global foothold as a leader in…

Continue Reading

ThursdayDec 30, 2021 10:37 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at Tribe Public’s Webinar Event

InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced that its CEO Eric A. Adams, SVP and General Manager of BayMedica, Shane Johnson, and VP of Commercial Operations Chris Meiering will present at Tribe Public’s upcoming webinar presentation and Q&A event. The event, titled “Addressing the Increasing Demand for Rare Cannabinoids,” is slated to begin at 8 a.m. Pacific/11.a.m. Eastern on Jan. 6, 2022. Interested parties should visit https://cnw.fm/rKO43 to register to join the complimentary, ZOOM webinar-based event. Once registered, participants may begin forwarding their questions for InMed and BayMedica’s management to…

Continue Reading

WednesdayDec 29, 2021 1:06 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Approval from Independent Review Board for DehydraTECH-CBD Human Clinical Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has received Independent Review Board ("IRB") approval for its planned DehydraTECH-CBD human hypertension study HYPER-H21-4; the approval was received earlier than anticipated. The study is designed to "de-risk" outcomes prior to the company’s planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease. The six-week study, which is entirely funded through the existing cash resources, is planned to include 60 volunteers, aged 45 to 70, using three 150 mg doses of DehydraTECH-CBD daily for the duration of the study. Dosing…

Continue Reading

WednesdayDec 22, 2021 2:32 pm

CannabisNewsBreaks – Genius’ Flagship Innovation Revealed as Mystery Cannabis Pipe Smoked on ‘Sex and the City’ Reboot

Viewers noticed an unusual cannabis device being smoked in episodes one and two of the new HBOMax Series, “And Just Like That.” As it turns out, the device is a Genius Pipe that is shown in the premier episode of the “Sex and the City” reboot, where Carrie is clearly envious as Che lights up a sleek flat pipe and takes a hit as they ride an elevator together. In the second episode, Miranda catches her son Brady smoking weed. The same mystery pipe is dropped hard on the ground; however, the apparently sturdy pipe is undamaged and goes back into a pocket. The…

Continue Reading

WednesdayDec 22, 2021 12:25 pm

CannabisNewsBreaks – AmeriCann Inc.’s (ACAN) Massachusetts Cannabis Center Featured on Award-Winning Series

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today announced that its Massachusetts Cannabis Center was featured on the award-winning series by Dr. Sanjay Gupta on CNN exploring cannabis treatments for autism. “For nearly a decade Dr. Sanjay Gupta’s breakthrough series has shattered myths and introduced the healing properties of cannabis on a global stage,” said AmeriCann CEO Tim Keogh. “We are proud to play a role in helping Dr. Gupta present the considerable benefits that severe autism patients have achieved being treated with cannabis.” To view the full press release, visit https://cnw.fm/fIF9L…

Continue Reading

WednesdayDec 22, 2021 11:46 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Partners with Avicanna to Launch New Derma-Cosmetic Brand

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, is working with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to unveil a new THC-free, CBD derma-cosmetic brand. The first known CBD skincare line to be clinically tested and commercialized across four international markets, Pura H&W will include seven SKUs of proprietary products. The products are formulated using a combination of purified CBD and other synergistic botanical ingredients designed to naturally regulate and nourish the skin. The Pura H&W product line was developed by Avicanna and specific products have undergone clinical trials.…

Continue Reading

MondayDec 20, 2021 12:31 pm

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Ranks in List of Top 101 Canadian F&B Startups and Companies

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has been named one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. The ranking recognizes the company’s leadership position within both the food & beverage and cannabis product categories. Companies listed in the rankings include cutting-edge startups and established brands alike, but each company is known for innovation within their sector, exceptional growth and societal impact. BevCanna was within the group of selected companies that exhibited exceptional performance. In addition, BVNNF was also included within…

Continue Reading

ThursdayDec 16, 2021 10:54 am

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Collaborate with OMNI Medical Services for Cannabis Study in Treatment of COVID-19

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced plans for a U.S. clinical study focused on treatment COVID-19. RYAH will be partnering with OMNI Medical Services to perform the U.S.-based clinical study evaluating patients using inhalation of medical cannabis to both treat and prevent the coronavirus. The study, which will run for five years, will involve the use of RYAH’s Smart Inhaler devices and will involve up to 11,000 of OMNI’s patients across the country. Phase 2 of the…

Continue Reading

WednesdayDec 15, 2021 1:44 pm

CannabisNewsBreaks – Marijuana Company of America Inc. (MCOA) Completes Strategic Acquisition, Expands Footprint in Country’s Largest Cannabis Market

Marijuana Company of America (OTC: MCOA), a diversified holding company with operations and investments throughout the cannabis industry, today announced that it has recently completed the acquisition of VBF Brands Inc. A Salinas, California-based marijuana cultivator and distributor, VBF was previously a wholly-owned subsidiary of Sunset Island Group Inc. (OTC: SIGO). MCOA expects that, based on activity since the acquisition was consummated in Q3 2021, the transaction will continue to be highly accretive to the company's EBITDA expectations for 2022 and will work towards increasing production at a nearby Salinas-based facility that also offers exponential growth opportunities with other nearby…

Continue Reading

TuesdayDec 14, 2021 1:27 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Study Results Expected to Demonstrate DehydraTECH-CBD’s Effectiveness Against Hypertension

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its human clinical study HYPER-H21-3 is expected to complete all dosing and sample collection this week. The study, undertaken to examine the effects of DehydraTECH-CBD upon acute pulmonary hypertension, used a blinded design with administration of a single 300mg dose of a specific DehydraTECH 2.0 CBD formulation compared to placebo in a target group of sixteen enrolled volunteers. Subject to pending analysis of samples collected from the study, blood pressure results are expected to be reported soon. Exposure to acute reductions in oxygen tension (i.e.,…

Continue Reading